Exo Therapeutics
PrivateLast Round
Series B
Oct 5, 2021
Total Funding Raised
$103M
Company Overview
Exo Therapeutics is a biotechnology company that develops small-molecule drug candidates targeting exosites to reprogram enzyme activity for the treatment of oncology and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exo Therapeutics Comparables
Compare Exo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HotSpot Therapeutics | 85% | |
| Nutshell Therapeutics | 79% | |
| Eisbach Bio GmbH | 76% |
Exo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 5, 2021 | ||||
| Series A | Dec 16, 2020 |
Exo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series B, Series A |
| Morningside Ventures | Series B |
| BVF Partners L.P. | Series B |
| CRV | Series B, Series A |
| Casdin Capital | Series B |
| Nextech Invest | Series B |
| 6 Dimensions Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2020
$25M round led by CRV.
Exo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exo Therapeutics's valuation, stock price, and market status.
Is Exo Therapeutics a public or private company?
Exo Therapeutics is a private company.
What is the current stock price of Exo Therapeutics?
Exo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Exo Therapeutics worth (valuation)?
Valuation information for Exo Therapeutics is not publicly available.
Can I buy Exo Therapeutics stock?
Exo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Exo Therapeutics's last funding round?
Exo Therapeutics's most recent funding round was Series B on October 5, 2021.
Who are the main investors in Exo Therapeutics?
Key investors in Exo Therapeutics include CRV, Nextech Invest.
Will Exo Therapeutics IPO soon?
No public IPO plans have been announced for Exo Therapeutics.
How can I track Exo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Exo Therapeutics's secondary market activity and sign up for updates.